The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFrontier Ip Regulatory News (FIPP)

Share Price Information for Frontier Ip (FIPP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 41.50
Bid: 40.00
Ask: 43.00
Change: 0.00 (0.00%)
Spread: 3.00 (7.50%)
Open: 41.50
High: 41.50
Low: 41.50
Prev. Close: 41.50
FIPP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Agreement with FCT, Universidade NOVA de Lisboa

14 Sep 2016 11:50

RNS Number : 8333J
Frontier IP Group plc
14 September 2016
 

AIM: FIPP

14 September 2016

 

Frontier IP Group Plc

("Frontier IP" or the "Group")

 

Agreement with the Faculty of Science and Technology of Universidade NOVA de Lisboa

 

Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that it has today signed an agreement with the Faculty of Science and Technology within the Universidade NOVA de Lisboa, Portugal ("FCT NOVA") to assist with its spin-off and licensing activities emerging from its research programmes. This partnership is Frontier IP's second in Portugal and reflects the Group's view that there is significant opportunity in the region.

 

The Universidade NOVA de Lisboa is a research-intensive university (QS Top Universities 2016) and FCT NOVA, its engineering school, has particular research strengths in Materials, Environment, Energy, Biotechnology, Conservation and Restoration. Frontier IP and FCT NOVA will work together to maximise the commercial value of intellectual property developed within or owned by FCT NOVA. Frontier IP will receive a share of equity in each spin-off company created by FCT NOVA, as well as a share in the licensing revenue it receives.

 

FCT NOVA is an active research collaborator, both within Portugal and internationally, and its partners include Massachusetts Institute of Technology (MIT), the University of Carnegie Mellon and the University of Texas at Austin, amongst others. The collaboration with Frontier IP aims to accelerate value creation from the research generated within FCT NOVA and provide access to early stage funding, commercialisation expertise and a wider network of industrial partners.

 

The signing of the agreement was attended by Her Majesty's Ambassador to the Portuguese Republic, Mrs Kirsty Hayes. Addressing the audience, the Ambassador emphasised the importance of effective commercialisation of the intellectual property being generated through the investment in research and development in Portugal's universities. The UK has strong experience of intellectual property commercialisation and it has been a principle focus for British universities to develop a portfolio of intellectual property which has relevance to the business world.

 

Her Majesty's Ambassador to the Portuguese Republic, Mrs Kirsty Hayes, said:

 

"I am delighted by the announcement of this important agreement between Frontier IP and FCT NOVA, which will drive the commercialisation of intellectual property from one of the leading Portuguese universities, which has a strong reputation for investment in research and development. This agreement represents a further strengthening of collaboration between Portugal and the United Kingdom."

 

Neil Crabb, Chief Executive of Frontier IP, said:

 

"We are delighted that FCT NOVA has chosen us as its commercialisation partner. This agreement gives us access to FCT NOVA's excellent research base and builds on the strong relationships with the industrial partners and academic institutions which we have already established in the region. We are looking forward to working with FCT NOVA to further develop and commercialise its strong intellectual property portfolio."

 

Dr. Fernando Santana, Director of FCT NOVA, said:

 

"Frontier IP has a strong reputation in the commercialisation of university-based technologies. We hope that this agreement will bring increased international visibility to FCT NOVA's portfolio, making it an even more successful institution by maximizing the impact of its knowledge. This shows FCT NOVA's commitment to innovation, which benefits the institution and the wider society it serves."

 

Enquiries

 

Frontier IP Group Plc

 

T: 0131 240 1251

Neil Crabb, Chief Executive

 

 

Company website: www.frontierip.co.uk

 

 

 

Cantor Fitzgerald Europe

(Nominated Adviser and Joint Broker)

 

T: 020 7894 7000

David Foreman, Catherine Leftley, Corporate Finance

 

 

David Banks, Sales

 

 

 

 

 

Peterhouse Corporate Finance Limited

(Joint Broker)

 

T: 020 7469 0935

Lucy Williams

 

 

 

 

 

Kreab

 

T: 020 7074 1800

Robert Speed, Matthew Jervois

 

 

 

 

Notes to Editor:

 

About Frontier IP Group plc

www.frontierip.co.uk 

Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin-out companies by taking an active involvement in the commercialisation and funding of these businesses.

 

About Universidade NOVA de Lisboa, Faculty of Science and Technology

http://www.fct.unl.pt

FCT NOVA is one of the most prestigious Portuguese engineering and science public schools and it is engaged in extensive research activity developed in 16 research centres involving 1600 PhD and Master's students and a total of 550 academic staff (90% holding a Ph.D). FCT NOVA partners with foreign universities such as the Massachusetts Institute of Technology (MIT), the University of Carnegie Mellon and the University of Texas at Austin to offer some of its advanced study programs. The entrepreneurial drive of the students and graduates of FCT NOVA has led to many successful spin-offs that transfer knowledge to the market and help create value and social impact.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
AGRLLFSIARISLIR
Date   Source Headline
29th Jul 20209:11 amRNSHolding(s) in Company
28th Jul 20205:22 pmRNSHolding(s) in Company
22nd Jul 202012:50 pmRNSHolding(s) in Company
21st Jul 20209:05 amRNSSecond Price Monitoring Extn
21st Jul 20209:00 amRNSPrice Monitoring Extension
21st Jul 20207:00 amRNSResult of Capital Raising
20th Jul 20204:37 pmRNSPrimaryBid.com Offer
20th Jul 20204:35 pmRNSProposed Capital Raising of a minimum of £2m
20th Jul 20202:00 pmRNSCambridge Raman Imaging completes £250,000 funding
14th Jul 20207:00 amRNSAquaInSilico wins grant to commercialise software
13th Jul 20207:00 amRNSPulsiv demonstrates strong progress
7th Jul 20207:00 amRNSCelerum supports development for PlanSea Solutions
6th Jul 20207:00 amRNSBosch collaboration with Fieldwork
30th Jun 20205:00 pmRNSTotal Voting Rights
23rd Jun 20207:00 amRNSThe Vaccine Group: strong COVID-19 progress
17th Jun 20207:00 amRNSCambridge & FIPP collaborate to tackle gum disease
28th May 20207:10 amRNSPortfolio news: Access to Elute's Patent Reader
28th May 20207:00 amRNSExercise of Options and Total Voting Rights
26th May 20207:00 amRNSPortfolio news – Exscientia raises $60 million
7th May 20207:00 amRNSExscientia and SRI International collaborate
1st May 20207:00 amRNSPortfolio news – Molendotech raises £425,000
15th Apr 20207:00 amRNSPortfolio news – Pulsiv Solar awarded patent
9th Apr 20207:00 amRNSPortfolio news: Alusid launches luxury Block range
6th Apr 202012:01 pmRNSHolding(s) in Company
1st Apr 20207:00 amRNSExscientia announces joint initiative re COVID-19
30th Mar 20204:40 pmRNSSecond Price Monitoring Extn
30th Mar 20204:36 pmRNSPrice Monitoring Extension
30th Mar 20207:00 amRNSElute Intelligence’s AI to back COVID-19 research
26th Mar 20207:00 amRNSPortfolio news: new portfolio company AquaInSilico
25th Mar 20207:00 amRNSUnaudited Half Year Results
19th Mar 20207:00 amRNSFrontier partners University of Lisbon competition
17th Mar 20203:15 pmRNSNotice of interim results
13th Mar 20207:00 amRNSPortfolio news – The Vaccine Group Update
12th Mar 202011:05 amRNSSecond Price Monitoring Extn
12th Mar 202011:00 amRNSPrice Monitoring Extension
19th Feb 202012:37 pmRNSHolding(s) in Company
17th Feb 20207:00 amRNSCRIL wins EUR140,000 EU Graphene Flagship funding
12th Feb 20207:00 amRNSPortfolio news - FIPP increases stake in Celerum
31st Jan 20207:00 amRNSPortfolio news - Exscientia
20th Jan 20207:00 amRNSPortfolio news - The Vaccine Group raises £680,000
16th Jan 20203:28 pmRNSHolding(s) in Company
14th Jan 20207:00 amRNSFieldwork Robotics secures first equity funding
10th Jan 20207:00 amRNSExscientia enters collaboration with Bayer AG
31st Dec 20191:00 pmRNSTotal Voting Rights
16th Dec 201910:36 amRNSExercise of Options and Issue of Equity
11th Dec 20196:03 pmRNSHolding(s) in Company
9th Dec 20193:25 pmRNSHolding(s) in Company
9th Dec 20193:21 pmRNSHolding(s) in Company
9th Dec 20192:08 pmRNSHolding(s) in Company
9th Dec 20199:46 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.